Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep46 | Adrenal cortex | ECE2015

Adrenal insufficiency during prednisolone treatment: need for cortisol replacement strategies in patients on long-term low-dose glucocorticoid treatment?

Borresen Stina Willemoes , Baslund Bo , Klose Marianne , Rasmussen AEse Krogh , Friis-Hansen Lennart , Hilsted Linda , Locht Henning , Hansen Annette , Hetland Merete Lund , Feldt-Rasmussen Ulla

Background: Patients on long-term glucocorticoid treatment are at risk of adrenal insufficiency during glucocorticoid treatment. The side effect can occur during glucocorticoid treatment if there is a mismatch between glucocorticoid requirements and production/intake. High-dose glucocorticoid treatment is often sufficient to overcome most stressful situations. A low-dose of 5 mg prednisolone/day is however, equivalent to 20 mg hydrocortisone, a dose often used as basal glucoco...

ea0049ep40 | Adrenal cortex (to include Cushing's) | ECE2017

Predictive baseline morning P-cortisol levels for the response to a Synacthen test in prednisolone treated patients

Borresen Stina Willemoes , Klose Marianne , Locht Henning , Laursen Toke , Jensen Bente , Hilsted Linda , Baslund Bo , Rasmussen AEse Krogh , Friis-Hansen Lennart , Hansen Annette , Hetland Merete Lund , Feldt-Rasmussen Ulla

Introduction: Evaluation of glucocorticoid production generally requires a dynamic test. Cut-off levels for baseline cortisol concentrations predicting the outcome of a Synacthen test have been proposed for different cortisol assays. With introduction of the new Roche Elecsys Cortisol II assay, P-cortisol concentrations are expected to decrease by 20%. We have investigated cut-off levels for baseline P-cortisol concentrations measured with the Roche Elecsys Cortisol II assay t...